Market Speculation Swirls Around Potential Shift from Quarterly Earnings Reports Wholesale Inflation Surges 6 Annually in April Marking Highest Level Since 2022 Fed Rate Hike Expectations Resurface as Inflation Data Surges UK Government Borrowing Exceeds Forecasts in April as Inflation Raises Benefits Costs Beyond to Purchase Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond Mercury Achieves 52 Billion Valuation After 200M Funding Round Defying Fintech Downturn TransUnion Q1 2026 Earnings EPS Surges Past Estimates Shares Edge Higher UWMC Q1 2026 Earnings EPS Surprises to the Upside as Mortgage Market Stabilizes PAR Technology Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Execution Lunai Bioworks Inc LNAI Q1 2026 Earnings EarlyStage Biotech Delivers Strategic Progress Despite GAAP Loss Vivani Medical Q1 2026 Earnings Narrower Net Loss Surpasses Expectations Cencora COR Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Resilient Operations Golden Heaven Group Holdings GDHG Retreats Key Support Levels Under Scrutiny After 284 Decline StoneBridge Acquisition II Corporation APAC Holds Steady at 1012 SPAC Trading in a Tight Range Soren Acquisition Corp SORN Holds Steady at 992 as Support and Resistance Define Trading Range Here Group Limited Slides to 235 Support Test in Focus Matthews International MATW Holds Steady Near Support Levels Amid Modest Decline JAKK Q1 2026 Earnings NarrowerThanExpected Loss Lifts Investor Sentiment BVN Q4 2025 Earnings Stunning EPS Beat Driven by Operational Strength and Higher Metal Prices Thomson Reuters TRI Q1 2026 Earnings EPS Beats Estimates on Operational Strength Kewaunee Scientific Corporation KEQU Q1 2026 Earnings Reports 028 EPS Revenue Details Not Disclosed agilon health Q1 2026 Earnings Massive EPS Beat Drives Stock Surge INTG Q1 2026 Earnings Solid EPS Lifts Stock Despite Limited Disclosures Morgan Stanley Adjusts Palo Alto Networks Stock Price Target Amid Demand Trends ABCL Q1 2026 Earnings EPS Surprises to the Upside as Biotech Continues Development eXoZymes Inc EXOZ Climbs 313 as Biotech Stock Tests Key Resistance at 1074